Downstream Bio-Processing Controllers’ Market Size 2030
The latest market report published by Credence Research, Inc. "Global Downstream Bio-processing Controllers’ Market: Growth, Prospects, and Competitive Analysis, 2016 – 2030". The global Downstream Bio-processing Controllers’ Market generated revenue of around USD 849.5 million in 2022 and is anticipated to grow a CAGR of over 17.30% during the forecast period from 2017 to 2030 to reach around USD 2212.84 million in 2030.
Downstream processing is the recovery and purification of biosynthetic goods, for pharmaceutical products, from their natural states, such as broth, plant, and animal tissues. The primary driver for the global downstream bio-processing controllers' market is the rising medical research investments, which are expected to grow with the biopharmaceutical sector. Rising R&D activities among the prominent players and continuous adoption of downstream controllers within various systems such as multicomponent separations, perfusion chromatography systems, high-throughput process development, and high-resolution membrane systems. These factors are expected to fuel the growth of the global downstream bio-processing controllers' market.
The global downstream bio-processing controllers' market is bifurcated into Procedure, Product, Application, End Users, and Geography. Based on procedure, the market is categorized into tangential flow filtration and chromatography. Based on product, the global market is segmented into tangential flow filtration and chromatography. Based on application, the market can be categorized into commercial bioprocessing and research bioprocessing. Based on end user, the market can be split into pharmaceutical & biotechnology companies, contract manufacturing organizations, and academic & research institutes. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Downstream bio-processing controllers are used in the manufacturing of proteins, peptides, and other biomolecules from biological sources such as cells or cell lysates. They are used to monitor and control key process parameters such as pH, temperature, dissolved oxygen (DO), and conductivity.
The rising prevalence of chronic diseases such as cancer and diabetes is driving the demand for biologics. Biologics are used in the treatment of these diseases as they are more effective than small molecule drugs. The increasing number of approvals for biologics is projected to fuel the market growth over the forecast period.
Some of the key players operating in the downstream bio-processing controllers market include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, and GE Healthcare.
Why to Buy This Report-
· The report provides a qualitative and quantitative analysis of the global downstream bio-processing controllers’ by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2017-2021, base year- 2022, and forecast period 2017-2030.
· The report contains information related to the competitive landscape, like how the key players in the market are operating at a global, regional, and country level.
· In-depth analysis of the global downstream bio-processing controllers’ segmentation based on products, procedures, applications, end user, and regional integration.
· The global downstream bio-processing controllers’ report also includes analysing the global, regional, and country levels, key market trends, significant players analysis, market growth strategies, and key application areas.
Browse Full Report: https://www.credenceresearch.com/report/downstream-bio-processing-controllers-market
Visit: https://www.credenceresearch.com/
Browse Our Blog: https://tealfeed.com/downstream-bio-processing-controllers-market-size-irgt6
Browse Our Blog: https://www.linkedin.com/pulse/downstream-bio-processing-controllers-market-size-expected-singh